Skip to main content

meningococcal group B vaccine 60 ug/.5mL / 60 ug/.5mL Medicare Part D Coverage

Brand name: Trumenba
Dosage form
INJECTION, SUSPENSION
Route
INTRAMUSCULAR
100%
of Medicare Part D plans
cover meningococcal group B vaccine
5,529 of 5,530 plans
2.3
Avg. formulary tier
$12.00
Median 30-day copay
$0.00–$24.00
Copay range

Formulary Tier Distribution

How Medicare Part D plans classify meningococcal group B vaccine. Lower tiers = lower copays.

Tier 1 - Preferred Generic 53%
2,955 plans • avg $0.01/mo
Tier 2 - Generic 1%
28 plans • avg $1.15/mo
Tier 3 - Preferred Brand 33%
1,843 plans • avg $10.82/mo
Tier 6 - Select Care 13%
703 plans • avg $0.00/mo

Find the cheapest plan for meningococcal group B vaccine

Enter your ZIP code to compare every plan in your area side-by-side.

Compare Plans for meningococcal group B vaccine →

Get meningococcal group B vaccine Delivered to Your Door

Compare prices and get discounts from trusted online pharmacies

DrugCovered may earn commissions from pharmacy purchases. Prices and availability vary. Always consult your doctor before starting or changing medications.

meningococcal group B vaccine Medicare Coverage by State

Coverage rates and average costs vary significantly by state. Click a state to see the specific plans available there.

Frequently Asked Questions about meningococcal group B vaccine

100% of Medicare Part D plans cover meningococcal group B vaccine. It is most commonly placed on Tier 2. Coverage varies by plan and geographic area.

The median 30-day copay for meningococcal group B vaccine on Medicare Part D is $12.00 at a preferred pharmacy. Costs range from $0.00 to $24.00 depending on the plan.

meningococcal group B vaccine is placed on Tier 2 by most Medicare Part D plans. Lower tier numbers generally mean lower copays.

0% of plans require prior authorization for meningococcal group B vaccine. Prior authorization means your doctor must confirm the drug is medically necessary before the plan will cover it.

Coverage statistics based on CMS formulary data for plan year 2026. Data updated regularly. Methodology →